ENTITY

Dynavax Technologies (DVAX US)

4
Analysis
Health CareUnited States
Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.
more
Refresh
Company Event07 Aug 2024 04:30 • Upcoming
Add To Calendar
Company Event09 May 2024 04:30 • Latest
Company Event23 Feb 2024 05:30
Company Event01 Feb 2024 23:00 • Upcoming
Add To Calendar
Company Event03 Nov 2023 04:30
x